儿童肝炎相关的无形性贫血
1Department of Pediatrics, Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, Indianapolis, Indiana.
Pediatric annals
|November 10, 2025
概括
肝炎相关无形性贫血 (HAAA) 是一种罕见的,严重的疾病,肝炎导致骨髓衰竭. 早期诊断和多学科治疗对于管理这种危及生命的疾病至关重要.
科学领域:
- 血液学 血液学 血液学
- 肝病学 肝病学是一种肝病学.
- 儿科 儿科 儿科
背景情况:
- 肝炎相关无形性贫血 (HAAA) 是一种罕见的,危及生命的疾病.
- 儿科医生是识别肝炎进展为骨髓衰竭的关键.
研究的目的:
- 审查HAAA的诊断和治疗复杂性.
- 强调需要一个多学科的方法来管理HAAA.
主要方法:
- 对病理生理学,诊断策略 (免疫类型,骨髓活检) 和管理 (免疫抑制疗法,干细胞移植) 的审查.
- 包括新出现的病毒触发器,包括SARS-CoV-2.
主要成果:
- HAAA涉及免疫介导的骨髓抑制.
- 有效的管理需要治疗方法的结合和提高临床意识.
结论:
- 标准化治疗策略和早期干预对于改善HAAA的结果至关重要.
- 需要提高对潜在的病毒触发器 (如SARS-CoV-2) 的认识.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
188
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
157
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
157
Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
219
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
219
Pharmacokinetics in Pediatric Patients: Drug Distribution
231
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Immunodeficiency Diseases
1.9K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.9K


